- Home
- MCK
as 05-30-2025 10:39am EST
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
| Founded: | 1833 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 88.8B | IPO Year: | N/A |
| Target Price: | $691.42 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 25.72 | EPS Growth: | 14.87 |
| 52 Week Low/High: | $464.42 - $731.00 | Next Earning Date: | 05-08-2025 |
| Revenue: | $359,051,000,000 | Revenue Growth: | 16.22% |
| Revenue Growth (this year): | 14.2% | Revenue Growth (next year): | 7.86% |
Stock Insider Trading Activity of McKesson Corporation (MCK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Smith LeAnn B | MCK | EVP & Chief HR Officer | May 28 '25 | Sell | $717.91 | 341 | $244,807.31 | 2,800 | |
| Rodgers Thomas L | MCK | EVP, Chief Strategy & BDO | May 28 '25 | Sell | $717.91 | 510 | $366,134.10 | 5,435 | |
| Rutledge Napoleon B JR | MCK | SVP, Controller & CAO | May 28 '25 | Sell | $717.91 | 95 | $68,201.45 | 986 | |
| Smith LeAnn B | MCK | EVP & Chief HR Officer | May 23 '25 | Sell | $715.24 | 161 | $115,153.64 | 2,800 | |
| Smith LeAnn B | MCK | EVP & Chief HR Officer | May 21 '25 | Sell | $717.30 | 1,248 | $895,190.40 | 2,800 | |
| TYLER BRIAN S. | MCK | Chief Executive Officer | Mar 6 '25 | Sell | $634.24 | 8,962 | $5,684,058.88 | 42,741 |
Latest McKesson Corporation News
MCK Breaking Stock News: Dive into MCK Ticker-Specific Updates for Smart Investing
MT Newswires
7 hours ago
McKesson Insider Sold Shares Worth $1,348,235, According to a Recent SEC Filing
Zacks
a day ago
Why McKesson (MCK) is a Top Value Stock for the Long-Term
MT Newswires
a day ago
Nephron Research Adjusts McKesson Price Target to $780 From $750
Zacks
2 days ago
Here's Why McKesson (MCK) is a Strong Momentum Stock
Zacks
2 days ago
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Zacks
3 days ago
MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?
Simply Wall St.
7 days ago
An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 33% Undervalued
Zacks
8 days ago
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?
Compare MCK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MCK McKesson Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.